3-(2,2,2-trimethylhydrazine)propionate has been researched along with Ischemia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Arıkök, AT; Bozkurt, H; Ergüder, Bİ; Gürer, B; Kertmen, H; Kuru Bektaşoğlu, P; Ozaydin, D; Sargon, MF; Türe, D | 1 |
| Afanas'ev, VV; Murashko, NK | 1 |
| Gutcaits, A; Kalvinsh, I; Sjakste, N | 1 |
1 review(s) available for 3-(2,2,2-trimethylhydrazine)propionate and Ischemia
| Article | Year |
|---|---|
Mildronate: an antiischemic drug for neurological indications.
Topics: Animals; Cardiovascular Agents; Drug Evaluation; Humans; Ischemia; Ketone Bodies; Methylhydrazines; Models, Biological; Neuropharmacology; Nitric Oxide; Toxicology | 2005 |
2 other study(ies) available for 3-(2,2,2-trimethylhydrazine)propionate and Ischemia
| Article | Year |
|---|---|
Mildronate Has Ameliorative Effects on the Experimental Ischemia/Reperfusion Injury Model in the Rabbit Spinal Cord.
Topics: Animals; Antioxidants; Caspase 3; Catalase; Disease Models, Animal; Ischemia; Malondialdehyde; Methylprednisolone; Neuroprotective Agents; Peroxidase; Rabbits; Reperfusion Injury; Spinal Cord; Spinal Cord Ischemia | 2023 |
[Mildronat--treatment of cardio-neurologic pathology in ischemia and hypoxia].
Topics: Cardiovascular Agents; Cardiovascular Diseases; Cerebrovascular Circulation; Cerebrovascular Disorders; Energy Metabolism; Humans; Hypoxia; Ischemia; Methylhydrazines; Randomized Controlled Trials as Topic | 2012 |